Cargando…
Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
BACKGROUND: Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed in the brain exclusively on microglia and genetic variants are linked to neurodegenerative diseases including Alzheimer’s disease (AD), frontotemporal dementia (FTD) and Nasu Hakola Disease (NHD). The Trem2 variant R47...
Autores principales: | Jadhav, Vaishnavi S., Lin, Peter B. C., Pennington, Taylor, Di Prisco, Gonzalo Viana, Jannu, Asha Jacob, Xu, Guixiang, Moutinho, Miguel, Zhang, Jie, Atwood, Brady K., Puntambekar, Shweta S., Bissel, Stephanie J., Oblak, Adrian L., Landreth, Gary E., Lamb, Bruce T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594478/ https://www.ncbi.nlm.nih.gov/pubmed/33115519 http://dx.doi.org/10.1186/s13024-020-00409-0 |
Ejemplares similares
-
TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation
por: Moutinho, Miguel, et al.
Publicado: (2023) -
The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease
por: Cheng-Hathaway, Paul J., et al.
Publicado: (2018) -
TREM2 in Neurodegenerative Diseases
por: Jay, Taylor R., et al.
Publicado: (2017) -
TREM2 deficiency eliminates TREM2(+) inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
por: Jay, Taylor R., et al.
Publicado: (2015) -
CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease
por: Puntambekar, Shweta S., et al.
Publicado: (2022)